EICHOR
● Active Not Recruiting
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
Condition: Platinum-resistant Ovarian Cancer · Sponsor: Genmab
About this study
This phase 3 study will be conducted in different countries all over the world. The purpose of this study is to compare how well Rina-S works against platinum-resistant ovarian cancer compared to chemotherapy drugs that are already approved and used for platinum-resistant ovarian cancer. Treatment in this study could be Rina-S or it could be 1 of 4 indicated chemotherapy agents that are considered standard medical care. There is an equal (50:50) chance of getting Rina-S or an approved chemotherapy agent as treatment in this study. No one will know what treatment they are assigned to until the first dose. All participants will receive active drug; no one will be given placebo.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (177)
| Alaska Women's Cancer Care | Anchorage, Alaska, United States | — |
| Arizona Center for Cancer Care (ACCC) - Biltmore | Scottsdale, Arizona, United States | — |
| University of Arizona Cancer Center - Research and Administration at Main Campus | Tucson, Arizona, United States | — |
| Providence Saint Joseph Medical Center - Roy and Patricia Disney Family Cancer Center | Burbank, California, United States | — |
| University of California San Diego Moores Cancer Center | La Jolla, California, United States | — |
| USCF Mission Bay | San Francisco, California, United States | — |
| Kaiser Permanente - Vallejo Medical Center | Vallejo, California, United States | — |
| UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center | Aurora, Colorado, United States | — |
| Hartford Hospital | Hartford, Connecticut, United States | — |
| Yale School of Medicine | New Haven, Connecticut, United States | — |
| Norwalk Hospital | Norwalk, Connecticut, United States | — |
| SCRI - Florida Cancer Specialists - South Region Research Office | Fort Myers, Florida, United States | — |
+ 165 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06619236